Open research questions in Vagus Nerve Stimulation Research
29 unresolved questions extracted from the limitations and future-work sections of 133 Vagus Nerve Stimulation Research papers in our library. Each links back to the study that raised it.
What the literature leaves open
Additionally, another limitation of this study is the use of an upper age limit in the eligibility criteria. Therefore, the results of this trial should be interpreted with appropriate caution, and future studies with larger samples and pooled effect estimates are warranted to further refine sample size assump- tions.
Evaluating the effect of bilateral transcutaneous auricular vagus nerve stimulation on motor function recovery after stroke: A multicenter, randomized controlled trial protocol · 2026 · DOISecond, the study only set an 8-week intervention without long-term follow-up, so the durability of taVNS antidepressant effects and the persistence of related brain function and gut microbiota alterations remain unclear. Several limitations of the present study should be noted. Third, this study only explored brain-gut interactions via correlation and mediation analyses without targeted interventional verification, failing to confirm the causal relationship; besides, single metagenomic analysis is insufficient to fully reveal the in-depth molecular mecha- nisms.
Exploring brain-gut interaction mechanisms in Transcutaneous auricular Vagus Nerve stimulation for Major Depressive Disorder · 2026 · DOIClinicalTrials.gov, NCT05370027. Registered on In this study, different devices were used for rightand left-hand measurements, which may have introduced technical variability and limited direct comparison of absolute HRV values across hands. To mitigate this, our primary inferences were based on pre–post change scores, and GSR was recorded only from the right hand due to device constraints. Autonomic measures are sensitive to contextual factors (e.g., stress, sleep, nutrition, circadian rhythm, and physical activity); although sessions were standardized and separated by at least 48 hours, residual carry-over or uncontrolled influences cannot be fully excluded. The study also assessed acute single-session effects only, without central nervous system or clinical outcomes, and included healthy participants; therefore, findings should be interpreted as mechanistic/hypothesis-generating rather than clinical efficacy. Finally, the absence of a sham condition limits causal inference regarding taVNS-specific effects. Future studies should use adequately poweres, randomized, sham-controlled, blinded designs and combine autonomic endpoints with central/clinical outcomes in patient populations characterized by dysautonomia. Device-specific sampling and proprietary preprocessing/algorithms may have influenced absolute HRV levels; therefore, cross-hand absolute comparisons should be interpreted descriptively. cONcLUsION In this acute, within-session evaluation, right-, left-, and bilateral taVNS were associated with shortterm changes in cardiovascular measures and selected HRV metrics. While bilateral stimulation showed the most consistent numerical pattern toward parasympathetic-related indices, the absence of a sham/ May 6, 2022. Data availability: The data that support the findings of this investigation are available upon request from the corresponding author. Patient consent: Information was kept confidential, the results of the survey were anonymous, and the responses could not be traced back to the participants. They consented to the survey by answering the questions.
Autonomic effects of unilateral and bilateral transcutaneous auricular vagus nerve stimulation in healthy adults: considerations for neurological applications · 2026 · DOIDespite this, VNS can drive CAIP-independent pathways to reduce inflammation in the spleen and intestinal tract, although the circuitry modulating colonic inflammation remains underexplored.
Vagus nerve stimulation limits colonic inflammation through distinct neuroimmune circuitry shaped by inflammatory history · 2026 · DOItypical perfused heart those of experiments, including the lack of erythrocytes and circulating hormones [41, 54]. Acute LAD ligation in the rat also does not fully recapitulate the complexity of a human MI due to differences in vasculature, collateral circulation, and autonomic control. Our short-term heart perfusion studies focused on the effect of acute activation of the cholinergic ICG neurons after an acute ischemic event. Long-term effects of cholinergic ICG neuron activation on infarct size and cardiac remodeling were not studied. Measurements of changes in epicardial fNADH and local tissue pO2 support the premise that improved after perfusion of cholinergic ICG neuron activation. However, changes in local tissue perfusion were not measured and will be pursued in future studies. Elevation of parasympathetic tone could also slow HR, cause AV block, and shorten action potential duration in the atria to promote atrial arrhythmias.
Chemogenetic activation of cholinergic intrinsic cardiac ganglia improves border zone oxygenation and reduces arrhythmias during acute local ischemia · 2026 · DOILong COVID exhibits complex features of inflammation, autonomic dysfunction, and metabolic abnormalities, many of which point to impaired vagus nerve-cardiopulmonary axis signaling and disrupted neuro-immune-metabolic interactions. Based on the integrated mechanistic framework and evidence presented in this review, future research and clinical translation may consider the following directions: 6.1 Phenotype-oriented stratification and candidate operational criteria Based on current clinical evidence and available guidelines, the identification of long COVID continues to rely primarily on a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, persistent symptoms lasting ≥ 3 months, and the exclusion of alternative diagnoses (Greenhalgh et al., 2024; Soriano et al., 2022). In the absence of definitive biomarkers, supplementary function testing, analysis of inflammatory and metabolic biomarkers, and standardized symptom scales—may help characterize the key pathophysiological features of individual patients. assessments—including autonomic The following criteria may serve as candidate operational standards for phenotypic stratification but do not currently constitute formal diagnostic criteria. They are intended to aid in patient selection, subgroup analysis, and the design of future clinical trials. Thresholds should be adapted to local laboratory reference ranges and validated prospectively.
Integrative perspectives on electroacupuncture modulation of vagal–cholinergic and neuro–immune–metabolic regulation in long COVID · 2026 · DOIConflict of interest remain The current evidence base has several important limitations. Most studies involve small sample sizes (typically 10–40 patients) and employ heterogeneous protocols, hindering definitive conclu- sions and optimal parameter identification. Study designs vary in rigor, with many lacking adequate blinding or sham controls. Outcome measures are inconsistent across studies, and long-term functional outcomes insufficiently characterized. Geographic concentration of certain studies (particularly for acu- puncture) raises concerns about publication bias. Mechanistic understanding of consciousness recovery and reliable predictors of treatment response remain incomplete. This narrative review provides qualitative synthesis rather than quantitative meta-anal- ysis and may not have captured all relevant studies, particularly non-English publications. As this is a narrative review without a formal PRISMA workflow or risk-of-bias assessment, caution should be exercised when interpreting statements about the over- all strength of evidence across modalities. The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Non-invasive neuroregulation techniques applied to patients with consciousness disorders: a narrative review · 2026 · DOIThe primary focus of these studies was to assess tolerabil- ity and the participant experience with taVNS, and our results are only applicable to the stimulation parameters included. In addition, both studies consisted of mostly young healthy individuals which potentially limited the amount of change seen in our secondary physiologic out- comes. Moreover, these findings may not be generaliz- able to clinical populations. Lastly, our results should be interpreted with caution due to the small sample sizes, especially for the secondary outcomes.
Participant-centered tolerability of transcutaneous auricular vagus nerve stimulation: insights from two crossover studies · 2026 · DOIThe study collects data on physiological and mechanistic understanding of auricular stimulation's effects on blood pressure control, exercise tolerance, and wellbeing through primary and secondary objectives, but does not specify the mechanistic pathways (parasympathetic activation, baroreceptor reflex modulation, sympathetic nervous system inhibition) that will be directly measured or validated.
A sham-controlled randomised trial evaluating the safety, acceptability, and efficacy of autonomic neuromodulation using transcutaneous vagal sensory stimulation in uncontrolled hypertensive patients: rationale and study design of the SCRATCH-HTN study · 2026 · DOIThe study compares tAN efficacy against renal denervation and antihypertensive medications but does not specify whether head-to-head comparative effectiveness trials between tAN and these interventions are planned, or what the minimum clinically important difference in blood pressure reduction should be for tAN to be considered superior.
A sham-controlled randomised trial evaluating the safety, acceptability, and efficacy of autonomic neuromodulation using transcutaneous vagal sensory stimulation in uncontrolled hypertensive patients: rationale and study design of the SCRATCH-HTN study · 2026 · DOIThe study's efficacy threshold is defined as >10 mmHg reduction in systolic blood pressure lasting >1 month post-discontinuation, but does not establish whether this criterion applies uniformly across subpopulations with different baseline hypertension severity, medication burden, or comorbidities in uncontrolled hypertensive patients.
A sham-controlled randomised trial evaluating the safety, acceptability, and efficacy of autonomic neuromodulation using transcutaneous vagal sensory stimulation in uncontrolled hypertensive patients: rationale and study design of the SCRATCH-HTN study · 2026 · DOIThe study employed training protocols and reminders to maintain participant blinding in the active tAN arm, yet does not provide quantitative analysis of unblinding risk or report the specific sensitivity analyses planned to assess whether perceptions of treatment assignment differed between active and sham groups.
A sham-controlled randomised trial evaluating the safety, acceptability, and efficacy of autonomic neuromodulation using transcutaneous vagal sensory stimulation in uncontrolled hypertensive patients: rationale and study design of the SCRATCH-HTN study · 2026 · DOIThe study identifies transient side effects of transcutaneous auricular vagal stimulation (tAN) including light-headedness, fatigue, mood changes, and increased ventricular extrasystoles at <1% frequency, but does not specify the duration of these adverse events or long-term safety monitoring protocols required to characterize whether these effects truly diminish with sustained device usage.
A sham-controlled randomised trial evaluating the safety, acceptability, and efficacy of autonomic neuromodulation using transcutaneous vagal sensory stimulation in uncontrolled hypertensive patients: rationale and study design of the SCRATCH-HTN study · 2026 · DOIThe effectiveness of noninvasive transcutaneous VNS for epilepsy, depression, and other conditions has not been investigated beyond small pilot studies.
Despite well-defined anatomy, the mechanisms underlying its integrative roles in cardiovascular, metabolic, and neuropsychiatric regulation remain incompletely understood.
This increase in impedance has not been documented, meaning that the higher current might not be necessary and could produce avoidable adverse effects such as coughing.
At the anatomical level, vagus nerve fibers in the liver are relatively sparse and travel along the portal tripa, mainly terminating in the perihilar blood vessels and biliary tract ecological loci, with limited direct parenchymal synapses.
Vagal nerve innervation divergence in liver/pancreas: A forgotten key to endocrine recovery after transplantation? · 2026 · DOIAs the cross talk of the parasympathetic nervous system, the vagus nerve exerts organ-specific regulatory effects on hepatic and pancreatic endocrine homeostasis, yet its divergent innervation patterns and their implications for post-transplant functional recovery remain understudied.
Vagal nerve innervation divergence in liver/pancreas: A forgotten key to endocrine recovery after transplantation? · 2026 · DOIWhile the stomach is densely innervated by vagal afferents, the effect of GES on anxiety-related behavior has not been systematically examined.
Divergent Behavioral and Circuit-Level Adaptations to Acute and Chronic Gastric Electrical Stimulation · 2026 · DOIThe ability of tAN or transcutaneous auricular VNS (taVNS) to improve platelet function or laboratory hemostasis remains unknown.
Effects of transcutaneous auricular vagus nerve stimulation or combined vagal and trigeminal nerve stimulation on platelet function and laboratory hemostasis parameters in healthy human subjects · 2026 · DOITrigeminal nerve stimulation (TNS) also decreases traumatic hemorrhage in mice, but the mechanism remains unknown.
Effects of transcutaneous auricular vagus nerve stimulation or combined vagal and trigeminal nerve stimulation on platelet function and laboratory hemostasis parameters in healthy human subjects · 2026 · DOIDifferent neuromodulation modalities appear to target overlapping elements of these disrupted circuits, though the precise mechanisms remain to be fully elucidated, as many mechanistic interpretations currently derive from preclinical models rather than direct human evidence.
Non-invasive neuroregulation techniques applied to patients with consciousness disorders: a narrative review · 2026 · DOIThe observed trends towards significance in the active taVNS group warrant further investigation with larger cohorts and extended follow-up durations.
Transcutaneous Auricular Vagus Nerve Stimulation Combined with Continuous Antidromic Pelvic Neuromodulation and Rehabilitation for Recovery of Voluntary Locomotion in Spinal Cord Injury: An Exploratory Randomized Study · 2026 · DOIHowever, since taVNS research is still an emerging field, the underlying neurophysiological processes are not yet fully understood, and the replicability of findings on biomarkers of taVNS effects has been questioned.
Does transcutaneous auricular vagus nerve stimulation affect vagally mediated heart rate variability? A living and interactive Bayesian meta‐analysis · 2021 · DOI
Most-cited papers in Vagus Nerve Stimulation Research
- A body–brain circuit that regulates body inflammatory responses · Nature · 2024 · 323 citations
- Moving beyond belief: A narrative review of potential biomarkers for transcutaneous vagus nerve stimulation · Psychophysiology · 2020 · 144 citations
- Stress-sensitive neural circuits change the gut microbiome via duodenal glands · Cell · 2024 · 103 citations
- Innervation of nociceptor neurons in the spleen promotes germinal center responses and humoral immunity · Cell · 2024 · 95 citations
- Does transcutaneous auricular vagus nerve stimulation affect vagally mediated heart rate variability? A living and interactive Bayesian meta‐analysis · Psychophysiology · 2021 · 95 citations
- Transcutaneous Auricular Vagus Nerve Stimulation for Chronic Insomnia Disorder · JAMA Network Open · 2024 · 61 citations
- El derecho a la ciudad · New left review · 2008 · 53 citations
- An ingestible, battery-free, tissue-adhering robotic interface for non-invasive and chronic electrostimulation of the gut · Nature Communications · 2024 · 51 citations
- No evidence for a modulating effect of continuous transcutaneous auricular vagus nerve stimulation on markers of noradrenergic activity · Psychophysiology · 2022 · 37 citations
- Tacrolimus-Induced Neurotoxicity After Transplant: A Literature Review · Drug Safety · 2024 · 31 citations
Most recent work
- Auricular stimulation therapy: An evidence-based practice strategy for depression · Current Opinion in Pharmacology · 2026
- A deep representation learning model to predict response to vagus nerve stimulation · Nature Communications · 2026
- Transcutaneous auricular vagus nerve stimulation alleviates chronic heart failure by targeting cathepsin K/p53-mediated ferroptosis · Biology Direct · 2026
- Vagus-Decipher AI: Neural Decoding of Vagus Nerve Electrophysiology for Real-Time Prediction of Systemic Inflammatory Storms · Zenodo (CERN European Organization for Nuclear Research) · 2026
- Transcutaneous Auricular Vagus Nerve Stimulation Combined with Continuous Antidromic Pelvic Neuromodulation and Rehabilitation for Recovery of Voluntary Locomotion in Spinal Cord Injury: An Exploratory Randomized Study · Zenodo (CERN European Organization for Nuclear Research) · 2026
- A sham-controlled randomised trial evaluating the safety, acceptability, and efficacy of autonomic neuromodulation using transcutaneous vagal sensory stimulation in uncontrolled hypertensive patients: rationale and study design of the SCRATCH-HTN study · Frontiers in Cardiovascular Medicine · 2026
- Implantation of a passive electrical neurostimulation device achieves inflammatory modulation in rodents · Communications Biology · 2026
- Participant-centered tolerability of transcutaneous auricular vagus nerve stimulation: insights from two crossover studies · Bioelectronic Medicine · 2026
- A Review on Epilepsy: Recent Advancements in Modern Therapy · Zenodo (CERN European Organization for Nuclear Research) · 2026
- A standardized, surgically relevant map of organ-spesific branch emergence in the human vagus nerve · bioRxiv · 2026
Find a gap in your own Vagus Nerve Stimulation Research sub-topic
This page shows what the Vagus Nerve Stimulation Research literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →